Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?

1.28 Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?

Friss hírek egy helyen.

bulvárhírek

gazdasági hírek

autós hírek

életmód hírek

sporthírek

<< vissza

Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
Dátum: 2024-03-17 [news.yahoo.com]

A TELJES HÍR ELOLVASÁSA >>